Solutions Cepheid
Tester partout dans le monde
Diagnostics oncologiques
Bonne gestion des antibiotiques
Cepheid’s Insights
Webinaires
Cepheid RADAR
Support Center
Nous contacter
À propos de Cepheid
Mission et histoire
Notre leadership
Événements
Distributeurs
Opportunités de développement commercial
Innover avec Cepheid
Venez découvrir la moto Cepheid
Actualités
Xpert® Respiratory Panel
The Xpert Respiratory Panel is a multiplex, real-time PCR test for the qualitative detection and identification of 13 clinically relevant viral and bacterial respiratory pathogens in under 60 minutes. Performed on the GeneXpert System, Xpert Respiratory Panel delivers accurate, actionable results with minimal hands on time, helping laboratories and clinicians rapidly differentiate the causes of respiratory illness and support appropriate patient management.
13 viral and bacterial respiratory pathogens all in a single test.
Le besoin
La solution
L’impact
Influenza-like illness (ILI) can be caused by a range of viral and bacterial respiratory pathogens. Seasonal influenza alone causes millions of infections, up to 5 million severe cases and 650 000 deaths per year.1 Additional respiratory pathogens such as hMPV and Mycoplasma pneumoniae can also contribute to serious acute respiratory infections.2
Children, older adults, and immunocompromised individuals are among the populations at increased risk from infectious diseases.3
Timely diagnosis helps distinguish viral from bacterial infections, and support clinically informed patient management and antimicrobial stewardship efforts.4
1. https://www.who.int/news-room/fact-sheets/detail/influenza-%28seasonal%29
2. Trends of acute respiratory infection, including human metapneumovirus, in the Northern Hemisphere https://www.who.int/emergencies/disease-outbreak-news/item/2025-DON550 (Accessed October 2026)
3. Jim O’Neill, Tackling Drug-Resistant Infections Globally: Final Report And Recommendations, May 2016. https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf
4. Rapid multiplex PCR for respiratory viruses reduces time to result and improves clinical care: Results of a systematic review and meta-analysis. https://pubmed.ncbi.nlm.nih.gov/36906153/ (Accessed May 2026)
Broad respiratory pathogen coverage from a single sample to support confident clinical decisions. Xpert Respiratory Panel helps healthcare teams gain diagnostic insight while simplifying testing workflows.
Lab Manager
Support lab efficiency with timely identification of respiratory pathogens, maintaining workflow simplicity and efficient utilization of laboratory resources
Emergency Physician
Clinically relevant respiratory results designed to help support informed patient management decisions
Clinical Administrator
Ensure optimized use of healthcare resources supporting stewardship goals on isolation resources, testing pathways, and healthcare infrastructure
*Largest number of US-IVD tests running on a single system. 2025 IVD nucleic acid testing market analysis, June 2026. Data on file
†Cepheid GeneXpert® systems - Largest worldwide installed base for a single sample-to-answer PCR MDx testing system. 2025 IVD nucleic acid testing market analysis (based on secondary data from 3rd-party vendors triangulated with public company earnings reports and internal Cepheid analyses), June 2026. Data on file
A single PCR test to accurately detect 13 respiratory pathogens to support informed diagnostic decision
Consolidate respiratory testing on a single platform to streamline workflows, simplify laboratory operations, and optimize resource utilization
Simple steps in less than 1 minute that help with effective management of limited resources
CE-IVD. Dispositif médical de diagnostic in vitro. Peut ne pas être disponible dans tous les pays.
Cepheid's respiratory portfolio enables healthcare organizations to deploy diagnostic stewardship strategies on a single GeneXpert® platform. From targeted testing to comprehensive syndromic assessment, clinicians can select the right test for the right patient at the right time, supporting patient stratification, workflow efficiency, and effective utilization of healthcare resources.
Des résultats de dépistage d’infections respiratoires rapides et exploitables pour répondre aux défis des virus respiratoires en co-circulation.
Detection and identification of DNA and RNA from multiple bacteria, parasites and/or virus in ~ 74 minutes
Test de PCR qualitative en temps réel assurant une détection précise des streptocoques du groupe A en seulement 18 minutes*
Fiche Technique
ENG
Scientific Resource
ENG
